Skip to main content

Written Parliamentary Question: 14th February 2006

Private Finance Initiative

Q: To ask the Secretary of State for Health what the total capital sum is of each of the private finance initiative schemes over £10 million (a) in operation and (b) where the outline business case has been approved for which her Department is responsible; and what the (i) total optimism bias percentage, (ii) net value at commencement and (iii) amount of optimism bias for the public sector comparator is in respect of each scheme.(John Hemming)
A:Table 1 shows the capital value for all private finance initiative schemes over £10 million which are open. Table 2 shows the capital value for private finance initiative schemes which have reached financial close with work started on site or have advertised in the Official Journal of the European Union. All these schemes have an approved outlined business case.

The requirement to make explicit quantified adjustments for optimism bias in business cases, complementing the risk analysis already undertaken, was announced by Treasury in January 2003 and is applicable to national health service schemes that reached the invitation to negotiate stage from April 2003. Schemes which applied optimism bias are indicated in Table 2. This information is only available for schemes above £25 million. To collect and collate percentages and amounts of optimism for all these schemes could only be provided at disproportionate cost. (Jane Kennedy, Minister of State (Quality and Patient Safety), Department of Health)

Please follow the link to find the tables - ed.

Comments

Popular posts from this blog

Its the long genes that stop working

People who read my blog will be aware that I have for some time argued that most (if not all) diseases of aging are caused by cells not being able to produce enough of the right proteins. What happens is that certain genes stop functioning because of a metabolic imbalance. I was, however, mystified as to why it was always particular genes that stopped working. Recently, however, there have been three papers produced: Aging is associated with a systemic length-associated transcriptome imbalance Age- or lifestyle-induced accumulation of genotoxicity is associated with a generalized shutdown of long gene transcription and Gene Size Matters: An Analysis of Gene Length in the Human Genome From these it is obvious to see that the genes that stop working are the longer ones. To me it is therefore obvious that if there is a shortage of nuclear Acetyl-CoA then it would mean that the probability of longer Genes being transcribed would be reduced to a greater extent than shorter ones.